ArticleslgStudy

science

Lipofibromatosis-like neural tumor

Lipofibromatosis-like neural tumor is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Lipofibromatosis-like neural tumor rather than just read about it. In short: Lipofibromatosis-like neural tumor (LPF-NT) is an extremely rare soft tissue tumor first described by Agaram et al in 2016. As of mid-2021, at least 39 cases of LPF-NT have been reported in the literature.

Key takeaways

  • Lipofibromatosis-like neural tumor belongs to science; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Lipofibromatosis-like neural tumor to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Lipofibromatosis-like neural tumor from memory before moving on to harder problems.

Reference excerpt

Lipofibromatosis-like neural tumor (LPF-NT) is an extremely rare soft tissue tumor first described by Agaram et al in 2016. As of mid-2021, at least 39 cases of LPF-NT have been reported in the literature. LPF-NT tumors have several features that resemble lipofibromatosis (LPF) tumors, malignant peripheral nerve sheath tumors, spindle cell sarcomas, low-grade neural tumors, peripheral nerve sheath tumors, and other less clearly defined tumors; Prior to the Agaram et al report, LPF-NTs were likely diagnosed as variants or atypical forms of these tumors. The analyses of Agaram et al and subsequent studies uncovered critical differences between LPF-NT and the other tumor forms which suggest that it is a distinct tumor entity differing not only from lipofibromatosis but also the other tumor forms. LPF-NTs are locally invasive, are commonly treated by surgical excision, and have a relatively high rate of local recurrence if their surgical excisions are incomplete. They are generally considered to be benign, non-metastasizing (i.e. not spreading to other parts of the body) tumors. However, one case of LFT-NT reported by Agaram et al was associated with metastasis, apparently as a result of the tumor's cells transformation into a malignant sarcoma. Further studies are needed to determine the frequency of such cases and the overall metastatic potential of LPF-NT. LPF-NTs were given the "neural tumor" terminology because in at least some cases: 1) their tumor cells express S100 and CD34 but not SOX10 proteins, a pattern that is often found in neural and neuroectodermal tumor cells; and 2) their histopathology consists of tumor cell infiltrations into adipose tissues in a pattern that is very similar to that found in some low grade malignant peripheral nerve sheath tumors.

Presentation Lipofibromatosis-like neural tumors have been reported in the English literature to develop in children and young adults aged from 2 to 38 years (median age ~17 years). However, a recent study in the Chinese literature reported on three cases in infants <1 year old. LPF-NTs have almost always been superficially situated and occurring primarily in the legs and arms with fewer cases in the head, neck, and trunk areas. Three cases of primary and one case of recurrent LPF-NT tumors presented with infiltration into the adjacent skeletal muscles and one recently reported case presented with the tumor situated in, and limited to, the lumbar spine. The tumors have ranged from 1.3 cm to 8.7 cm in maximum diameter; may be tender but usually are painless (although the lumbar spine tumor presented with intermittent abdominal pain); and may be pigmented. In as high as 30% of cases, patients treated with surgical removal of the LPF-NT have presented with recurrent tumors at the site of surgery. The recurrent tumors have, in general, showed similar features to the primary tumors. In particular, they almost always continue to act in a non-malignant manner.

Pathology Histpathologically, hemotoxin and eosin dye-stained and otherwise properly prepared LPF-NT tissues consist of mildly to moderately atypical spindle-shaped cells that variably infiltrate into subcutaneous adipose (i.e. fat) tissues. The spindle-shaped cells commonly have indistinct nucleoli borders (nucleoli are the largest structures in a cell's nucleus), hyperchromasia (i.e. nuclei that are denser than normal), pale to slightly eosinophilic (i.e. taking up more eosin dye than normal) cytoplasm, and a low rate of cell division as determined by mitotic index analysis. Cases showing tissue necrosis (i.e. foci of dead or dying cells) are rare. The spindle-shaped cells espress S100 and CD34 marker proteins in a variable proportion of cases. One study found that the cells in five of five LDF-NTs overexpress, i.e. contain increased numbers of, one or more of the three Trk receptors (i.e. TrkA, TrkB, and TrkC) as judged using a pan-TRK immunohistochemistry assay. This assay uses a Pan-Trk antibody, i.e. an antibody that binds with and thereby enables the enumeration of all three Trk proteins. Other studies have found that this finding in LPF-NTs is due to overexpression of the TrkA receptor. Tumor tissues that have a histopathology compatible with LPF-NT plus spindle-shaped cells that express D34 and S100 but not SOX10 marker proteins are almost certainly LPF-NTs.

Gene abnormalities LPF-NT spindle-shaped cells usually express fusion genes which contain a portion of the NTRK1 gene which codes for (i.e. is responsible for producing) the TrkA receptor protein. Fusion genes are abnormal and potentially tumor-inducing genes formed by mergers between parts of two different genes that form as a result of chromosomal translocations, interstitial deletions, or inversions. The NTRK1 gene is located at bands 21 to 22 on the long (i.e "q") arm of chromosome 1. The most often observed NTRK1 fusion gene in LPF-NTs contains a part of NTRK1 fused with a part of the LMNA (i.e. lamin A/C) gene normally located close to the NTRK1 gene at band 22 on the q arm of chromosome 1. Other genes with which NTRK1 has been found to fuse with in LPF-NT are parts of: the TPR (i.e. translocated promoter region, nuclear basket protein) gene located at band 31.1 on the q arm of chromosome 1 and the TPM3 (i.e. tropomyosin 3) gene located at band 21.3 on the q arm of chromosome 1. All three of these fusion genes result from interstitial deletions of the genetic material between a part of the NTRK1 gene and a part of the cited genes on chromosome 1. In studies of LPF-NT tumors on small numbers of individuals, NTRK1-containing fusion genes were detected in 71%, i.e. 10 of 14 individuals, 80%, i.e. 4 of 5 individuals, and 100%, i.e. 5 of 5 individuals with LPF-NT. Individuals diagnosed with non-neural lipofibromatosis have not been reported to harbor NTRK1-containing fusion genes. The protein products (termed fusion proteins or chimeric proteins) of the three NTRK1-containing fusion genes possess overactive and unregulated TrkA, i.e. tropomyosin receptor kinase A, activity that stimulates the PI3K/AKT/mTOR, MAPK/ERK, and PLCG1 cell signaling pathways. Each of these pathways are known to promote the development and/or progression of a large variety of benign and malignant tumors. Studies have suggested that one or more of these pathways may drive LPF-NT.

… excerpt ends here. Continue reading the full article.

Worked examples

Example 1 — a first encounter with Lipofibromatosis-like neural tumor

Start with the simplest possible case. Write down what Lipofibromatosis-like neural tumor claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Lipofibromatosis-like neural tumor before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Lipofibromatosis-like neural tumor ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Lipofibromatosis-like neural tumor

In research
Lipofibromatosis-like neural tumor appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Lipofibromatosis-like neural tumor in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Lipofibromatosis-like neural tumor is common in secondary-school and first-year university syllabi. It links to neighbouring topics Benign neoplasms, Connective and soft tissue neoplasms, Dermal and subcutaneous growths, so understanding it makes those chapters shorter.
In everyday life
Look for Lipofibromatosis-like neural tumor outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Lipofibromatosis-like neural tumor” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Lipofibromatosis-like neural tumor in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Lipofibromatosis-like neural tumor means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Lipofibromatosis-like neural tumor out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Lipofibromatosis-like neural tumor in simple terms?

Lipofibromatosis-like neural tumor (LPF-NT) is an extremely rare soft tissue tumor first described by Agaram et al in 2016. As of mid-2021, at least 39 cases of LPF-NT have been reported in the literature.

Why does Lipofibromatosis-like neural tumor matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Lipofibromatosis-like neural tumor?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Lipofibromatosis-like neural tumor.

Tags

  • Benign neoplasms
  • Connective and soft tissue neoplasms
  • Dermal and subcutaneous growths

Keep exploring